Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025

Page 9 of 14

6. Accolade Inc (NASDAQ:ACCD)

Number of Hedge Fund Holders In Q3 2024: 24

Accolade Inc (NASDAQ:ACCD) is a tech-enabled healthcare company.

It has risen significantly so far in 2025 after an acquisition announcement.

Transcarent will acquire Accolade for $7.03 per share in cash. The deal is expected to close in Q2 2025.

The company’s Q2 2025 results showed 10% year-over-year growth and a 277% reduction in net losses.

Management projected first full-year adjusted EBITDA profitability this year.

The consensus price target of $7.55 implies 8.91% upside.

ACCD stock is up 102.63% year-to-date.

Page 9 of 14